Treatment of bone complications in advanced prostate cancer: Rationale for bisphosphonate use and results of a phase III trial with zoledronic acid
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (6 Suppl 21) , 19-27
- https://doi.org/10.1053/sonc.2002.37418
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: